Volume 22, Number 1—January 2016
Dispatch
Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea1
Figure

Figure. Study protocol for investigating risk for contracting ESBL-producing Enterobacteriaceae among travelers from Finland with TD. LO–AMD–, not treated with medication; LO+AMD–, treated with LO alone; LO–AMD+, treated with AMDs alone; LO+AMD+, treated with a combination of both drugs. AMD, antimicrobial drugs; ESBL, extended-spectrum β-lactamase; LO, loperamide; TD, travelers’ diarrhea.
1Preliminary results from this study were presented at the 13th Conference of the International Society of Travel Medicine (CISTM), May 24–28, 2015, Quebec City, Quebec, Canada.